What Can Drive A 15% Downside To CME’s Stock In The Next 2 Years?

+4.03%
Upside
219
Market
228
Trefis
CME: CME Group logo
CME
CME Group

There could be almost a 15% downside to our price estimate for CME in the next few years if the rate per contract for financial derivatives grows at a slower than expected pace, owing to the increasing competition in the financial markets. This in turn may negatively affect revenues from financial derivatives. The table below shows what would drive the downside.

kk1 kk2 kk3

Relevant Articles
  1. Up 26% YTD, What’s Next For CME Group Stock?
  2. What To Expect From CME Group Stock?
  3. What To Expect From CME Group Stock?
  4. CME Group Stock To Top The Street Expectations In Q4
  5. What To Expect From CME Group Stock?
  6. CME Group Stock To Beat The Street Expectations In Q3?

Have more questions about CME? See the links below:

Notes:

1) The purpose of these analyses is to help readers focus on a few important things. We hope such lean communication sparks thinking, and encourages readers to comment / ask questions on the comments section
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to the full Trefis analysis for CME Group.

View Interactive Institutional Research (Powered by Trefis):
Global Large CapU.S. Mid & Small CapEuropean Large & Mid Cap
More Trefis Research